According to Ys Biopharma latest financial reports the total liabilities of YS is $139.77M, an decrease of -53.69% to 2022. At the end of 2022 company had $301.83M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Ys Biopharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $139.77M | -53.69% |
2022 | $301.83M | - |
2021 | $236.31M | 33453747.88% |
2020 | $706.38 | - |